SEC 13F Intelligence

Vestor Capital, LLC / ABBV

Vestor Capital, LLC’s Abbvie Inc Position

Does Vestor Capital, LLC own Abbvie Inc (ABBV)? Yes71.8K shares worth $16M (+1.13% of its 13F portfolio) as of Q1 2026, down from 441.7K shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
71.8K
% of Portfolio
+1.13%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $1MQ2 ’19: $1MQ3 ’19: $1MQ4 ’19: $2MQ4 ’19Q1 ’20: $956,000Q3 ’20: $1MQ4 ’20: $1MQ1 ’21: $1MQ1 ’21Q2 ’21: $1MQ3 ’21: $1MQ4 ’21: $2MQ1 ’22: $10MQ1 ’22Q2 ’22: $16MQ3 ’22: $4MQ4 ’22: $5MQ1 ’23: $5MQ1 ’23Q2 ’23: $2MQ3 ’23: $2MQ4 ’23: $2MQ1 ’24: $3MQ1 ’24Q2 ’24: $2MQ3 ’24: $3MQ4 ’24: $7MQ1 ’25: $3MQ1 ’25Q2 ’25: $75MQ3 ’25: $3MQ4 ’25: $23MQ1 ’26: $16MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202671.8K$16M+1.13%
Q4 2025441.7K$23M+1.58%
Q3 202513.7K$3M+0.20%
Q2 2025271.1K$75M+5.60%
Q1 202513.7K$3M+0.24%
Q4 202438.1K$7M+0.52%
Q3 202413.5K$3M+0.21%
Q2 202413.5K$2M+0.19%
Q1 202413.9K$3M+0.21%
Q4 202313.9K$2M+0.21%
Q3 202313.5K$2M+0.22%
Q2 202314.2K$2M+0.20%
Q1 202330.5K$5M+0.57%
Q4 202231.7K$5M+0.62%
Q3 202232.7K$4M+0.58%
Q2 2022103.7K$16M+1.92%
Q1 202263.1K$10M+1.01%
Q4 202112.9K$2M+0.17%
Q3 202113.3K$1M+0.15%
Q2 202112.2K$1M+0.14%
Q1 202112.2K$1M+0.15%
Q4 202012.2K$1M+0.16%
Q3 202012.2K$1M+0.15%
Q1 202012.6K$956,000+0.19%
Q4 201918.9K$2M+0.25%
Q3 201917.4K$1M+0.22%
Q2 201916.1K$1M+0.21%
Q1 201916.3K$1M+0.24%
Q4 201817.9K$2M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vestor Capital, LLC’s full portfolio or all institutional holders of ABBV.